
HROW
Healthcare · Drug Manufacturers - Specialty & Generic · $1.13B market cap
$30.12+1.82 (+6.4%)Nov 13, 4:20 PM EST
Next report
After the close
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +2.5% over 90 days · 30-day revisions 2 up, 1 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 1, 2027 · upcoming | After the close | 1.01 | — | — |
| Nov 9, 2026 | After the close | 0.13 | 0.12 | -7.7% |
| Aug 10, 2026 | After the close | -0.23 | -0.34 | -47.8% |
| May 11, 2026 | After the close | -0.33 | -0.74 | -124.2% |
| Mar 2, 2026 | Time not confirmed | 0.39 | 0.27 | -31.1% |
| Nov 10, 2025 | After the close | 0.29 | 0.33 | +13.8% |
| Aug 11, 2025 | After the close | 0.04 | 0.24 | +500.0% |
| May 8, 2025 | After the close | 0.01 | -0.38 | -3900.0% |
| Mar 17, 2025 | Before the open | 0.13 | 0.40 | +207.7% |
| Nov 13, 2024 | After the close | 0.07 | -0.05 | -171.4% |
| Aug 7, 2024 | After the close | -0.11 | -0.06 | +45.5% |
| May 13, 2024 | After the close | -0.25 | -0.28 | -12.0% |
| Mar 19, 2024 | After the close | -0.04 |
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE,…
| -0.25 |
| -525.0% |
| Nov 13, 2023 | After the close | 0.03 | -0.09 | -400.0% |
| Aug 9, 2023 | After the close | -0.04 | -0.02 | +50.0% |
| May 11, 2023 | After the close | -0.06 | -0.03 | +50.0% |
| Mar 23, 2023 | After the close | -0.12 | 0.04 | +133.3% |
| Nov 14, 2022 | After the close | -0.03 | -0.20 | -566.7% |
| Aug 9, 2022 | After the close | 0.01 | 0.01 | 0.0% |
| May 5, 2022 | After the close | -0.04 | 0.03 | +175.0% |
| Mar 10, 2022 | After the close | -0.04 | -0.27 | -575.0% |
| Nov 9, 2021 | After the close | -0.03 | 0.04 | +233.3% |
| Aug 10, 2021 | After the close | 0.04 | 0.09 | +125.0% |
| May 11, 2021 | After the close | 0.02 | 0.09 | +350.0% |
| Mar 8, 2021 | After the close | 0.04 | 0.04 | 0.0% |
| Nov 9, 2020 | After the close | -0.09 | 0.04 | +144.4% |
| Aug 10, 2020 | After the close | -0.17 | -0.14 | +17.6% |
| May 11, 2020 | After the close | -0.02 | -0.04 | -100.0% |
| Mar 13, 2020 | Before the open | 0.06 | 0.10 | +66.7% |
| Nov 13, 2019 | After the close | -0.04 | -0.29 | -625.0% |
| Aug 14, 2019 | After the close | -0.06 | -0.05 | +16.7% |
| May 9, 2019 | After the close | -0.12 | -0.04 | +66.7% |
| Mar 12, 2019 | After the close | 0.34 | 0.77 | +126.5% |
| Nov 13, 2018 | After the close | -0.09 | -0.12 | -33.3% |
| Aug 6, 2018 | After the close | -0.12 | 0.11 | +191.7% |
| May 15, 2018 | After the close | -0.16 | -0.17 | -6.3% |
| Mar 8, 2018 | After the close | — | -0.13 | — |